SynAct Pharma AB · OMXSTO:SYNACT
TJ Biotech Holding ApS bought 3,529 SynAct Pharma AB shares (MAR article 19 notification)
Traded Dec 19, 2025 · Filed Dec 31, 2025 · Read by 6ix Oct 14, 2026
On Dec 19, 2025, TJ Biotech Holding ApS (Closely associated with Thomas Jonassen (Other senior executive)) bought 3,529 SynAct Pharma AB shares at SEK 20.45 for SEK 72,168. Filed Dec 31, 2025 (MAR article 19 notification).
- Bought
- 3,529 shares
- Price
- SEK 20.45
- Value
- SEK 72,168
- Role
- Closely associated with Thomas Jonassen (Other senior executive)
The register entry
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | SynAct Pharma AB | Buy | 3,529 | SEK 20.45 | Indirect |
Source
View original at Finansinspektionen
Related
- SynAct Pharma AB
- TJ Biotech Holding ApS
- SynAct Pharma AB shareholders
- MAR article 19 notification · TJ Biotech Holding ApS · Sep 7, 2026
- MAR article 19 notification · Quantass ApS · Nov 18, 2026
- MAR article 19 notification · Quantass ApS · Sep 7, 2026
- MAR article 19 notification · Anders Kronborg · Mar 10, 2026
- MAR article 19 notification · Quantass ApS · Mar 9, 2026
- MAR article 19 notification · Mads Liebach Bjerregaard · Mar 9, 2026